Table 1.
Characteristics of HIV-infected patients
| Characteristic | Lymphoma (N=19) |
Reactive adenopathy (N=22) |
p valuea |
|---|---|---|---|
| Age (years), mean ± SD | 47±11.7 | 50±9.7 | 0.424 |
| Sex, n | |||
| Male | 13 | 14 | 1.00 |
| Female | 6 | 8 | |
| Lymphoma subtypes, n | |||
| DLCBL | 16 | – | – |
| Hodgkin | 3 | – | – |
| PET/CT indications, n | |||
| Lymphoma diagnosis and staging | 19 | 0 | |
| Fever of unknown origin | 0 | 10 | |
| Pulmonary nodules | 0 | 12 | |
| Combination antiretroviral therapy | |||
| Yes | 18 | 13 | 0.011 |
| Antiretroviral therapy-naive | 1 | 9 | |
| Plasma HIV RNA (copies/mL, log10 scale) | |||
| Mean ± SD | 2.22±2.17 | 2.76±2.19 | 0.41 |
| Median | 2.07 | 3.24 | |
| CD4 count (cells/µl) | |||
| Mean ± SD | 356±344 | 428±359 | 0.31 |
| Viremia | |||
| Aviremia | 10 | 10 | 0.76 |
| Viremia | 9 | 12 | |
| Time from PET to last follow-up (years), median | 3.2 | 4.1 | 0.39 |
| Uptake time (min), mean ± SD | 62.6±9.5 | 62.0±10.6 | 0.79 |
| Dose (MBq), mean ± SD | 614.2±185 | 588.3±187 | 0.68 |
*
p values were based on Fisher's exact test for categorical predictors, or Wilcoxon's test for continuous predictors